VERV

Verve Therapeutics, Inc.

16.29 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Verve Therapeutics, Inc. stock is up 47.96% since 30 days ago. The next earnings date is May 13, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 2 March’s closed higher than February. In the last 5 Unusual Options Trades, there were 4 PUTs, 1 CALL.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
16 Jan 15:07 19 Jan, 2024 15.00 PUT 218 792
16 Jan 18:53 19 Jan, 2024 15.00 PUT 381 792
27 Feb 20:05 17 May, 2024 17.50 PUT 100 20
27 Feb 20:06 17 May, 2024 17.50 PUT 100 20
27 Feb 20:49 16 Aug, 2024 15.00 CALL 208 68

About Verve Therapeutics, Inc.

Verve Therapeutics, Inc. engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver.